Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.

Influenza Virus Clinical Trial

Official title:
A Phase III, Stratified, Randomized, Observer Blind, Controlled, Multicenter Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Adjuvanted Comparator Influenza Vaccine in Children ≥6 to < 72 Months of Age.

Status Completed

Clinical Trial Summary

Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Adjuvanted Comparator Influenza Vaccine in Children ≥6 to <72 Months of Age. The study was conducted during the 2013/2014 and 2014/2015 northern hemisphere influenza season.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01964989
Study type	Interventional
Source	Seqirus
Contact
Status	Completed
Phase	Phase 3
Start date	November 2013
Completion date	August 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00998803` - Surveillance of Influenza Virus Shedding and Immunologic Response in Immunocompromised Children and Young Adults	N/A
Completed	`NCT00760175` - Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Lung Transplant Recipients	N/A
Recruiting	`NCT05375006` - Tropism and Pathogenesis of Influenza Virus and Coronavirus in Human Brain Explant Culture
Completed	`NCT01561807` - A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus	Phase 2